In recent years, treatment protocol for prostate cancer has been changing, and now a 10-year studys findings reveal there is no significant difference between using a "watch-and-wait" approach to monitor a tumor vs. undergoing treatment in early-stage cases as rock icon Rod Stewart went through in 2017.